This inventor holds 1 USPTO granted patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xiang Li: Innovator in Humanized Anti-TRKA Antibodies
Introduction
Xiang Li is a prominent inventor based in Dongguang, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Xiang Li holds a patent for "Humanized Anti-TRKA Antibodies and Uses Thereof." This innovative patent highlights his expertise in creating antibodies that target specific proteins, which can lead to improved treatment strategies for patients.
Career Highlights
Xiang Li is associated with Sunshine Lake Pharma Co., Ltd., where he applies his knowledge and skills to further research and development in the pharmaceutical industry. His dedication to innovation has positioned him as a key player in his field.
Collaborations
Xiang Li has collaborated with notable colleagues, including Zhiheng Ren and Junji Dong. These partnerships enhance the research efforts and contribute to the success of their projects.
Conclusion
Xiang Li's work in humanized antibodies represents a significant advancement in biotechnology. His contributions are paving the way for new therapeutic solutions, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile